Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
Future Oncology (London, England)|February 18, 2021
Association of illness perception with chemotherapy-induced nausea and vomiting: a Turkish Oncology Group (TOG) studyTulay Kus, Gokmen Aktas, Melike Ozcelik, et al.Journal of Pharmaceutical Policy and Practice|May 26, 2016
Experiences from a pilot study on how to conduct a qualitative multi-country research project regarding use of antibiotics in Southeast EuropeSusanne Kaae, Sofia Kälvemark Sporrong, Janine Morgall Traulsen, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 4, 2016
Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG)Ali Alkan, Zeynep Gulsum Guc, Filiz Cay Senler, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 30, 2019
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group studyH Arzu Yaşar, Hande Turna, Ece Esin, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2018
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group studyYuksel Urun, H Arzu Yasar, Hande Turna, et al.Scientific Reports|May 9, 2024
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatmentMurat Bardakci, Hilal Karakas, Dogan Bayram, et al.Journal of Cancer Research and Therapeutics|July 18, 2024
Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric CancerAli Alkan, Dilşa Mızrak, Arzu Yaşar, et al.Clinical Breast Cancer|December 28, 2025
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) StudyAlper Türkel, İlknur Deliktaş Onur, Anıl Karakayalı, et al.Medicina (Kaunas, Lithuania)|May 4, 2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung CancerAli Aytac, Bilgin Demir, Meltem Demirtas Gulmez, et al.Value in Health Regional Issues|October 28, 2017
Cost Evaluation of Inhaler Therapies Used in Respiratory Diseases: 1998--2015 Period in TurkeyBanu Bayar, Nurcan Uman Kutkan, Esra Şafak Yılmaz, et al.Pageof 10